Brand-new toys from Disney, Marvel and more!

Open menu

  • Video
  • Shop
  • Culture
  • Family
  • Wellness
  • Food
  • Living
  • Style
  • Travel
  • News
  • Book Club
  • GMA3: WYNTK
  • Newsletter
  • Privacy Policy
  • Your US State Privacy Rights
  • Children's Online Privacy Policy
  • Interest-Based Ads
  • Terms of Use
  • Do Not Sell My Info
  • Contact Us
  • © 2023 ABC News
  • News

Pfizer CEO on coronavirus vaccine: 'We feel very good about the safety'

VIDEO: Pfizer says there are 'no safety concerns' about its vaccine
6:07
Pfizer says there are 'no safety concerns' about its vaccine
ABCNews.com
ByTommy Brooksbank
November 09, 2020, 1:36 pm

Pfizer CEO Dr. Albert Bourla joined “GMA3: What You Need To Know” Monday to discuss the drug-maker's coronavirus vaccine after early analysis shows it to be 90% effective at preventing COVID-19.

"The vaccine was proven to be very efficacious, overwhelmingly,” Bourla said. “That was big news for me as well. We feel very good about the safety.”

Editor’s Picks

What it’s like to be a school nurse during the COVID-19 pandemic

  • Nov 06, 2020

Pfizer announces initial Phase 3 data showing its vaccine is 'more than 90% effective'; more safety data needed before FDA authorization

  • Nov 09, 2020

Biden and Harris launch transition COVID-19 advisory board

  • Nov 09, 2020

The company, along with co-developer BioNTech, published safety data reviewed by an independent data-monitoring board over the weekend that found 94 COVID-19 infections in a study that enrolled nearly 44,000 people, which Bourla called “among the very good that we’ve seen in any vaccine so far.” Some participants got the vaccine while others received a placebo shot.

Dr. Anthony Fauci, the nation’s top-infectious disease expert, said the results suggesting 90% effectiveness are “just extraordinary," adding, "Not very many people expected it would be as high as that.”

“It’s going to have a major impact on everything we do with respect to COVID,” Fauci said.

Earlier this year, Fauci said he would be happy with a COVID-19 vaccine that was 60% effective. Scientists have warned for months that any COVID-19 shot may be only as good as flu vaccines, which are about 50% effective and require yearly shots.

MORE: Pfizer announces initial Phase 3 data showing its vaccine is likely effective

In a press release, Pfizer said it plans to seek emergency use authorization from the Food and Drug Administration once volunteers have been monitored for two months after getting their second dose of the vaccine, in accordance with guidelines by the FDA.

When asked about the public’s growing mistrust in rapid vaccine development, Bourla argued the pharmaceutical giant has been “extremely transparent” in publishing vaccine trial protocols and data before blaming politicians for stoking distrust.

“There is a lot of skepticism among individuals, among relative citizens of America that, frankly, they’re confused,” Bourla said. “I think the main reason for that is because instead of having scientists debating the merits of this vaccine, we had the politicians. This didn’t help at all.”

Bourla went on to highlight Pfizer’s decision not to partake in the Trump administration’s Operation Warp Speed.

“It’s not that we are arrogant or we believe that we can do it alone,” Bourla said. “And it’s not also that we don’t need the money. It’s a very big investment. But Pfizer did and it was a very difficult decision for me. The reason why I did it was because I wanted to liberate our scientists from any bureaucracy that could come by accepting money.”

Bourla added if the vaccine proves successful, he expects each dose to cost $20.

Related Topics
  • COVID-19 Vaccine

Editor’s Picks

What it’s like to be a school nurse during the COVID-19 pandemic

  • Nov 06, 2020

Pfizer announces initial Phase 3 data showing its vaccine is 'more than 90% effective'; more safety data needed before FDA authorization

  • Nov 09, 2020

Biden and Harris launch transition COVID-19 advisory board

  • Nov 09, 2020
Up Next in News—

US on brink of so-called child care cliff: 5 things for families to know as funding expires

September 29, 2023

Comedians say threats are not jokes in new Sandy Hook Promise gun violence PSA

September 27, 2023

'Just in shock': Dock worker assaulted in Montgomery brawl speaks out in 'GMA' exclusive

September 25, 2023

Quavo lobbies for gun violence prevention in D.C.

September 21, 2023

Up Next in News—

US on brink of so-called child care cliff: 5 things for families to know as funding expires

September 29, 2023

Comedians say threats are not jokes in new Sandy Hook Promise gun violence PSA

September 27, 2023

'Just in shock': Dock worker assaulted in Montgomery brawl speaks out in 'GMA' exclusive

September 25, 2023

Quavo lobbies for gun violence prevention in D.C.

September 21, 2023

The latest lifestyle and entertainment news and inspiration for how to live your best life - all from Good Morning America.
  • Contests
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Info
  • Children’s Online Privacy Policy
  • Advertise with us
  • Your US State Privacy Rights
  • Interest-Based Ads
  • About Nielsen Measurement
  • Press
  • Feedback
  • ABC News
  • ABC
  • All Videos
  • All Topics
  • Sitemap

© 2023 ABC News
  • Privacy Policy— 
  • Your US State Privacy Rights— 
  • Children's Online Privacy Policy— 
  • Interest-Based Ads— 
  • Terms of Use— 
  • Do Not Sell My Info— 
  • Contact Us— 

© 2023 ABC News